On April 27, 2021, members of the Access to Comprehensive Genomic Profiling (ACGP) participated in the Precision Medicine Leadership Summit’s Virtual Series on Genomics and Precision Medicine. Lauren Feldman, Vice President, Value, Access & Pricing at ADVI, moderated the panel “Comprehensive Genomic Profiling: A New Standard of Care in Oncology”, which covered:
- The landscape for comprehensive genomic profiling
- The obstacles to coverage & reimbursement
- Access to Comprehensive Genomic Profiling Coalition
The panelists were as follows: Mina Alsaraf Allo, PharmD, MPH, VP, Commercial Markets – East, Tempus, Trish Brown, MS, Director, AMR Payer Partner, Field Market Access Lead, Illumina, and Rob Dumanois, Director, Reimbursement Strategy, Thermo Fisher Scientific.
Access to Comprehensive Genomic Profiling (ACGP) is a collaborative coalition of leading molecular diagnostics companies and laboratories that aims to raise awareness about comprehensive genomic profiling (CGP) for advanced cancer patients. For more information, please visit: https://accesstocgp.com/